INFLUENCE OF PREVIOUS BROMOCRIPTINE THERAPY ON SURGERY FOR MICROPROLACTINOMA
- 15 January 1983
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 321 (8316) , 133-134
- https://doi.org/10.1016/s0140-6736(83)91782-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Clinical relevance of predictive tests for cancer chemotherapyCancer Treatment Reviews, 1982
- MENSTRUAL FUNCTION AND SERUM PROLACTIN LEVELS AFTER LONG-TERM BROMOCRIPTINE TREATMENT OF HYPERPROLACTINAEMIC AMENORRHOEAClinical Endocrinology, 1982
- Quantitation of drug sensitivity by human metastatic melanoma colony-forming unitsBritish Journal of Cancer, 1981
- A Broad Spectrum of Prolactin Suppression by Bromocriptine in Hyperprolactinemic Women: A Study of Serum Prolactin and Bromocriptine Levels after Acute and Chronic Administration ofBromocriptine*Journal of Clinical Endocrinology & Metabolism, 1980
- Results of surgery in 114 patients with prolactin-secreting pituitary adenomasAmerican Journal of Obstetrics and Gynecology, 1980
- Pretherapeutic detection of tumour resistance and the results of tumour chemotherapyPublished by Elsevier ,1979
- Growth Rate Patterns of Solid Tumors and Their Relation to Responsiveness to TherapyAnnals of Internal Medicine, 1978
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978
- Primary Bioassay of Human Tumor Stem CellsScience, 1977